Abstract Topics

• angiogenesis
• antibody engineering
• anticancer vaccines
• anti-inflammatory agents
• antisense
• APC
• apoptosis mechanisms
• arachidonic acid
• autoimmune disorders
• bioethics
• bioinformatics
• biomarker validation
• biotransformation enzymes
• bone marrow transplant
• breast disease
• cancer control strategies
• carcinogen bio-indicators
• cell cycle checkpoints
• cell cycle regulation
• chemoprevention
• chromatin structure
• chromosomal damage
• cofactors
• colon carcinogenesis
• COX-2 inhibitors
• cytokines
• dendritic cell vaccines
• diet
• differentiation
• DNA adducts, methylation
• drug development targets
• education & training
• endocrine disruptors
• environment-occupation
• epigenetics
• esophageal dysplasia
• exercise & weight control
• familial predisposition
• family cancer syndrome
• farnesyltransferase inhibitors
• field effects carcinogenesis
• gap junctions
• gastric dysplasia
• gene expression
• gene function modifiers
• gene therapy & vectors
• genetic counseling/testing
• genetic instability: multistep progression
• genetic polymorphisms
• genetic profiling
• genomic-based technology
• genomics
• growth factors & enzymes
• haplotypes
• health technology
• hematologic malignancies
• HER-2/neu
• hereditary malignancies
• high risk individuals
• histone modification enzymes
• H. pylori
• imaging
• immunobiology
• immunosurveillance
• immunotherapy
• intraepithelial neoplasias
• K-ras mutation
• legislation
• lifestyle
• LOH
• lymphomas & leukemias
• mammography
• matrix metalloproteinase
• melanomas
• metastasis
• microarray analysis
• microchip technology
• mitochondrial induction
• molecular-based histopathology
• molecular diagnosis
• molecular epidemiology
• molecular-targeted therapy
• molecular targets
• monoclonal antibodies
• multidrug resistance
• multiple gene interactions
• multistep carcinogenesis
• nutritional counseling
• nutrition & diet
• oncopharmacogenomics
• oxidative stress
• p450 methylation
• p53
• palliative care
• paraneoplastic changes
• pharmacogenomics
• physician awareness
• phytochemicals
• polymorphism
• PPAR
• precursor lesions
• predictive markers
• premalignant lesions
• preneoplastic conditions
• prevention programs
• prognostic indicators
• prostaglandin H synthase 2
• proteases: extracellular
• proteomics
• PSA testing
• psychosocial factors
• public health
• quality of life
• radiation enhancement
• receptors
• Resveratrol
• retinoids
• risk assessment
• risk perception
• screening
• signal transduction
• single nucleotide polymorphism (SNP)
• skin cancer
• stem cell biology
• stem cell transplantation
• sunscreens
• suppressor genes
• surveillance technics: genomic, microarray
• synergistic therapies
• telomerase inhibitors
• therapies: combined
• therapy vectors
• tobacco
• transplacental carcinogenesis
• tumor adjacent changes
• tumor supressor genes
• tyrosine kinase inhibitors
• ubiquitin
• vaccines
• viral oncogenesis